文献速递胃肠外科围术期管理与 ERAS

慢性肾病患者减重手术围术期结局的5年倾向匹配分析

A 5-year propensity-matched analysis of perioperative outcomes in patients with chronic kidney disease undergoing bariatric surgery.
PubMed 文献 · Surg Endosc · 2022-11-18

本研究基于MBSAQIP数据库2015-2019年数据,纳入717809例接受袖状胃切除(VSG)或Roux-en-Y胃旁路术(RYGB)的患者,其中5817例(0.8%)合并慢性肾病(CKD)。倾向匹配分析显示,CKD患者行VSG后出血、再入院、再手术、再干预及死亡率均高于非CKD患者,但透析与否不影响结局;相比RYGB,VSG在CKD患者中更安全。

要点

  • CKD患者行减重手术围术期并发症风险虽升高但总体可控,仍应视为手术候选。
  • CKD患者中VSG是首选术式,较RYGB深部器官间隙感染和再干预率更低。
  • 透析状态未显著影响围术期结局,CKD患者术后需保持警惕。

核心结论

  • CKD患者行减重手术的围术期不良事件风险增加,但绝对风险仍低,且对肾功能和肾移植候选资格的潜在获益大于风险,应视为手术候选。

研究设计与样本

  • 回顾性队列研究,查询MBSAQIP数据库2015-2019年数据,纳入717809例VSG或RYGB患者,按CKD状态分层,进行非匹配和倾向匹配分析比较30天围术期结局。

主要发现

  • 共5817例(0.8%)合并CKD,其中2266例(0.3%)接受透析;CKD患者中74.3%行VSG,25.7%行RYGB。
  • CKD患者行RYGB较VSG有更高的深部器官间隙感染率(0.7% vs. 0.1%,p=0.021)和再干预率(5.0% vs. 2.2%,p<0.001)。
  • VSG队列匹配分析显示,CKD患者较非CKD患者出血(2.1% vs. 0.9%,p<0.001)、再入院(9.3% vs. 4.9%,p<0.001)、再手术(2.7% vs. 1.3%,p<0.001)、再干预(2.2% vs. 1.3%,p<0.001)及死亡率(0.6% vs. 0.2%,p=0.003)均更高。
  • 肾功能不全与透析患者之间结局无差异。

临床怎么用

  • CKD合并肥胖患者行减重手术时应优先选择VSG而非RYGB。
  • 术前应充分告知CKD患者围术期并发症和死亡风险升高,术后加强监测。
  • 透析状态不应作为排除减重手术的依据。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bariatric surgery can improve renal function in patients with comorbid chronic kidney disease (CKD) and obesity. Additionally, bariatric surgery can enhance outcomes following renal transplantation. The safety of bariatric surgery in patients with CKD has been debated in the literature. This study evaluates the frequency of perioperative complications associated with CKD. METHODS: The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database was queried from 2015-2019. Patients were included if they had a vertical sleeve gastrectomy (VSG) or Roux-en-Y gastric bypass (RYGB) and were stratified based on CKD status. An unmatched and propensity-matched analysis was performed comparing 30-day perioperative outcomes between the groups. RESULTS: A total of 717,809 patients included in this study, 5817(0.8%) had CKD, of whom 2266(0.3%) were on dialysis. 74.3% of patients with CKD underwent VSG with 25.7% underwent RYGB. Comparing RYGB to VSG, patients who underwent RYGB had a higher rate of deep organ space infection (0.7%vs.0.1%,p = 0.021) and re-intervention (5.0% vs. 2.2%,p < 0.001). Within the VSG cohort, a matched analysis was performed for those with CKD and without CKD. The CKD cohort had higher risk of complications such as bleeding (2.1%vs. 0.9%,p < 0.001), readmission (9.3%vs.4.9%,p < 0.001), reoperation (2.7%vs.1.3%,p < 0.001), and need for reintervention (2.2%vs.1.3%,p < 0.001). Notably, patients with CKD also had a higher mortality (0.6%vs.0.2%,p = 0.003). No difference was seen between patients with renal insufficiency and patients on dialysis. CONCLUSION: VSG has been the operation of choice in patients with CKD. Our results showed it is the safer option for patients with CKD compared to RYGB. Although this patient population does have an increased risk of adverse perioperative events, dialysis didn't affect the outcome. Bariatric surgeons who operate on patients with CKD should be well informed and remain vigilant given the increased perioperative risk. The risk is still considerably low, and the potential benefit on renal function and improvement in candidacy for renal transplant outweigh the risk. They should be considered as surgical candidates.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Aboueisha MA, Evans L, Allotey JK, et al. A 5-year propensity-matched analysis of perioperative outcomes in patients with chronic kidney disease undergoing bariatric surgery. Surg Endosc. 2022. PMID: 36401102. doi:10.1007/s00464-022-09756-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。